Ejaz Ansari

882 total citations
35 papers, 553 citations indexed

About

Ejaz Ansari is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Ejaz Ansari has authored 35 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Surgery. Recurrent topics in Ejaz Ansari's work include Glaucoma and retinal disorders (18 papers), Retinal Diseases and Treatments (11 papers) and Corneal surgery and disorders (8 papers). Ejaz Ansari is often cited by papers focused on Glaucoma and retinal disorders (18 papers), Retinal Diseases and Treatments (11 papers) and Corneal surgery and disorders (8 papers). Ejaz Ansari collaborates with scholars based in United Kingdom, Netherlands and United States. Ejaz Ansari's co-authors include J. Camilleri, James C. Martin, C Lane, N. Amos, Ellen M. Van Cann, Robert J.J. van Es, Najiba Chargi, Remco de Bree, François J. Dieleman and Antoine J.W.P. Rosenberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Ophthalmology.

In The Last Decade

Ejaz Ansari

29 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ejaz Ansari United Kingdom 12 355 240 123 63 47 35 553
Fatih Özçura Türkiye 13 365 1.0× 267 1.1× 284 2.3× 17 0.3× 36 0.8× 50 574
Rocco Plateroti Italy 12 144 0.4× 116 0.5× 71 0.6× 44 0.7× 81 1.7× 23 369
Hee Seung Chin South Korea 16 515 1.5× 374 1.6× 188 1.5× 22 0.3× 65 1.4× 61 704
Ufuk Elgin Türkiye 16 653 1.8× 342 1.4× 78 0.6× 19 0.3× 81 1.7× 85 750
Konstantinos T. Tsaousis Greece 14 392 1.1× 264 1.1× 68 0.6× 32 0.5× 94 2.0× 64 563
Xu‐Lin Liao China 8 60 0.2× 79 0.3× 54 0.4× 16 0.3× 17 0.4× 38 250
Uğur Acar Türkiye 11 201 0.6× 156 0.7× 152 1.2× 55 0.9× 45 1.0× 49 428
Silvia Orengo-Nania United States 14 806 2.3× 577 2.4× 215 1.7× 19 0.3× 56 1.2× 32 967
Christina Lindén Sweden 19 859 2.4× 601 2.5× 222 1.8× 27 0.4× 55 1.2× 63 1.1k
E O'Donoghue United Kingdom 11 275 0.8× 137 0.6× 77 0.6× 17 0.3× 48 1.0× 19 403

Countries citing papers authored by Ejaz Ansari

Since Specialization
Citations

This map shows the geographic impact of Ejaz Ansari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ejaz Ansari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ejaz Ansari more than expected).

Fields of papers citing papers by Ejaz Ansari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ejaz Ansari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ejaz Ansari. The network helps show where Ejaz Ansari may publish in the future.

Co-authorship network of co-authors of Ejaz Ansari

This figure shows the co-authorship network connecting the top 25 collaborators of Ejaz Ansari. A scholar is included among the top collaborators of Ejaz Ansari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ejaz Ansari. Ejaz Ansari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ansari, Ejaz, et al.. (2025). Gold–NHC complexes: from synthetic aspects to anti-cancer activity. Dalton Transactions. 54(19). 7553–7601. 4 indexed citations
2.
Ansari, Ejaz, Robert J.J. van Es, François J. Dieleman, et al.. (2025). Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients. Oral Oncology. 169. 107628–107628.
3.
Ansari, Ejaz. (2024). The BVI ISOPURE® 123 intraocular lens: a new hydrophobic preloaded extended monofocal IOL with intermediate vision correction. SHILAP Revista de lepidopterología. 3. 1330335–1330335. 3 indexed citations
4.
Ansari, Ejaz, Robert J.J. van Es, François J. Dieleman, et al.. (2024). Low Skeletal Muscle Mass: A Strong Predictive Factor for Surgical Complications After Free Forearm Flap Reconstruction in Oral Cancer Patients. Head & Neck. 47(4). 1135–1141. 1 indexed citations
5.
Ansari, Ejaz, Laurent Ganry, Ellen M. Van Cann, & Remco de Bree. (2023). Impact of low skeletal muscle mass on postoperative complications in head and neck cancer patients undergoing free flap reconstructive surgery – A systematic review and meta-analysis. Oral Oncology. 147. 106598–106598. 3 indexed citations
6.
Ansari, Ejaz. (2023). Five-year outcomes of ab interno Xen 45 gel stent implantation. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(4). 1263–1269. 3 indexed citations
7.
Ansari, Ejaz, Manish I. Patel, & Deacon E. Harle. (2021). Acute community ophthalmology services provided by independent prescribing optometrists supporting hospital eye services during the COVID-19 outbreak. Journal of Optometry. 15(2). 175–178. 7 indexed citations
8.
Ansari, Ejaz. (2021). 10-year outcomes of first-line selective laser trabeculoplasty (SLT) for primary open-angle glaucoma (POAG). Graefe s Archive for Clinical and Experimental Ophthalmology. 259(6). 1597–1604. 17 indexed citations
9.
Ansari, Ejaz, Blake Anderson, & Katalin Kauser. (2020). Retained Functionality of Atherosclerotic Human Arteries Following Photoactivated Linking of the Extracellular Matrix by Natural Vascular Scaffolding Treatment. Journal of Cardiovascular Translational Research. 14(3). 441–448. 2 indexed citations
10.
12.
Ansari, Ejaz, et al.. (2018). Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens. Ophthalmology and Therapy. 7(2). 397–403. 13 indexed citations
13.
Ansari, Ejaz, et al.. (2017). Prescribing Trends in a Glaucoma Clinic and Adherence to EGS Guidelines: A Retrospective, Non-Interventional, Single-Center UK Study. Advances in Therapy. 34(8). 2033–2042. 14 indexed citations
14.
Ansari, Ejaz. (2017). An Update on Implants for Minimally Invasive Glaucoma Surgery (MIGS). Ophthalmology and Therapy. 6(2). 233–241. 77 indexed citations
15.
Ansari, Ejaz. (2013). IOP Maintenance in SLT-treated Eyes following Subsequent Phacoemulsification and IOL. JOURNAL OF CURRENT GLAUCOMA PRACTICE. 7(1). 17–18. 1 indexed citations
16.
Ansari, Ejaz & Nadir Ali. (2008). Intraocular Pressure Following Intravitreal Injection of Triamcinolone Acetonide§. The Open Ophthalmology Journal. 2(1). 119–122. 8 indexed citations
18.
Morgan, James P., Nik Sheen, Rachel V. North, et al.. (2005). Discrimination of Glaucomatous Optic Neuropathy by Digital Stereoscopic Analysis. Ophthalmology. 112(5). 855–862. 27 indexed citations
19.
Ansari, Ejaz. (2002). Psychophysical characterisation of early functional loss in glaucoma and ocular hypertension. British Journal of Ophthalmology. 86(10). 1131–1135. 48 indexed citations
20.
Ansari, Ejaz, A J Morrell, & Kanika Sahni. (1997). Corneal perforation and decompensation after automated lamellar keratoplasty for hyperopia. Journal of Cataract & Refractive Surgery. 23(1). 134–136. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026